000 | 01980 a2200637 4500 | ||
---|---|---|---|
005 | 20250514162718.0 | ||
264 | 0 | _c20040920 | |
008 | 200409s 0 0 eng d | ||
022 | _a0042-9007 | ||
024 | 7 |
_a10.1111/j.0042-9007.2003.364_1.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEngelfriet, C P | |
245 | 0 | 0 |
_aCurrent status of immunoprophylaxis with anti-D immunoglobin. _h[electronic resource] |
260 |
_bVox sanguinis _cNov 2003 |
||
300 |
_a328-37 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
650 | 0 | 4 |
_aDrug Utilization _xstatistics & numerical data |
650 | 0 | 4 |
_aErythroblastosis, Fetal _xprevention & control |
650 | 0 | 4 | _aEurope |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 |
_aPractice Patterns, Physicians' _xstatistics & numerical data |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aPregnancy Complications _ximmunology |
650 | 0 | 4 |
_aPrenatal Care _xstatistics & numerical data |
650 | 0 | 4 |
_aRh Isoimmunization _xtherapy |
650 | 0 | 4 |
_aRho(D) Immune Globulin _xtherapeutic use |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aReesink, H W | |
700 | 1 | _aJudd, W J | |
700 | 1 | _aUlander, V-M | |
700 | 1 | _aKuosmanen, M | |
700 | 1 | _aKoskinen, S | |
700 | 1 | _aRouger, P | |
700 | 1 | _aMorelati, F | |
700 | 1 | _aTantalo, V | |
700 | 1 | _aFujii, T | |
700 | 1 | _ade Haas, M | |
700 | 1 | _avan der Schoot, C E | |
700 | 1 | _aOverbeeke, M | |
700 | 1 | _aKoelewijn, J | |
700 | 1 | _aBonsel, G | |
700 | 1 | _aVrijkotte, T | |
700 | 1 | _aZupaĆska, B | |
700 | 1 | _aMartin-Vega, C | |
700 | 1 | _aParra Lopez, R | |
700 | 1 | _ade Silva, M | |
700 | 1 | _aContreras, M | |
700 | 1 | _aPanzer, S | |
700 | 1 | _aUlm, B | |
700 | 1 | _aMayr, W R | |
773 | 0 |
_tVox sanguinis _gvol. 85 _gno. 4 _gp. 328-37 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.0042-9007.2003.364_1.x _zAvailable from publisher's website |
999 |
_c14369499 _d14369499 |